Elucidating the role of ATF6α as a critical pro-fibrogenic transcription factor in Hepatic Stellate Cells
阐明 ATF6α 作为肝星状细胞中关键的促纤维化转录因子的作用
基本信息
- 批准号:10526974
- 负责人:
- 金额:$ 11.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-01 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:ATAC-seqAddressAlgorithmsApoptosisApoptoticAutophagocytosisAutophagosomeBacteriophagesCRISPR/Cas technologyCell SurvivalCellsCellular StressChromatinCicatrixCirrhosisDataData SetDegradation PathwayDepositionEndoplasmic ReticulumExcisionExhibitsExtracellular Matrix ProteinsExtracellular SpaceFibrosisGene ExpressionGenesGenetic TranscriptionGoalsHealthHepatic Stellate CellHepatocyteImpairmentIn VitroInjectionsLiverLiver FailureLiver FibrosisLiver diseasesMembraneMusMyofibroblastOlive oil preparationPatientsPersonsPhage ReceptorsPhenotypePhysiologic OssificationPrevalenceProcessProcollagenProductionProtein BiosynthesisProtein SecretionProteinsRegulationResearch PersonnelRoleSamplingSecretory CellSignal TransductionStarvationStimulusStressTherapeuticTissuesTransforming Growth Factor betaUp-RegulationWorkactivating transcription factorcell typechromatin remodelingchronic liver injurydelta opioid receptorendoplasmic reticulum stressfibrogenesisglobal healthin vivoinsightliver functionliver injurymRNA sequencingmisfolded proteinnovelprogramsprotein degradationprotein foldingproteostasisreceptorresponsesensortranscription factortranscriptome sequencing
项目摘要
Cirrhosis is a global health crisis that develops in response to chronic liver injury. Liver injury activates Hepatic
Stellate Cells (HSCs) which differentiate into fibrogenic myofibroblasts. Fibrogenic HSCs produce and secrete
vast amounts of matrix proteins that deposit into the extracellular space leading to fibrosis, and if unchecked,
cirrhosis. While fibrosis is reversible upon removal of injurious stimuli, no therapies effectively promote fibrosis
regression. Production of matrix proteins by fibrogenic HSCs leads to excess proteins in the endoplasmic
reticulum (ER), placing stress on the ER. ER stress initiates the Unfolded Protein Response (UPR), a signaling
cascade allowing HSCs to adapt to increased protein load and facilitate efficient protein folding and secretion.
If ER stress is unresolved, UPR signaling switches from adaptive to pro-apoptotic. We propose that targeting
mechanisms facilitating HSC adaptation to ER stress would promote HSC apoptosis and limit
fibrogenesis, leading to fibrosis regression in vivo. Preliminary data shows that Activating Transcription
Factor 6α (ATF6α), a transcription factor and effector of the UPR, is crucial for HSC activation and survival in
vitro and fibrogenesis in vivo; however, the mechanisms underlying this role are unknown. RNAseq performed
on ATF6αΔ/Δ HSCs isolated from mice following 4 weeks of CCl4 injection revealed dysregulation of genes
involved in ossificaiton, protein degradation, apoptotic signaling, chromatin remodeling, and cellular response
to starvation compared to HSCs isolated from WT mice. We hypothesize that ATF6α activates
profibrogenic transcriptional programs to promote adaption of fibrogenic HSCs to ER stress and HSC
survival. Aim 1 will investigate the role of the ATF6α-regulated genes involved in ossification identified by our
RNAseq on HSCs isolated from mice with CCl4-induced fibrosis. We will additionally use RNAseq/ATACseq to
understand the short-term transcriptional impact of ATF6α deletion in HSCs. These analyses will reveal
ATF6α-dependent changes in the transcriptional and chromatin landscapes that drive fibrogenesis. Aim 2 will
study how ATF6α promotes HSC survival through ER-phagy: selective autophagic degradation of the ER. ER-
phagy is critical for secretory cell survival but its role in HSCs and fibrogenesis is unknown. We show that ER-
phagic flux increases in activated HSCs. Furthermore, ER-phagy receptors are upregulated in cirrhotic livers
and activated HSCs, and this upregulation is ATF6α-dependent. Aim 2 will study how ER-phagy maintains ER
function and promotes HSC survival to drive fibrogenesis, how ATF6α promotes ER-phagic flux in activated
HSCs, and the mechanisms by which key ER-phagy receptors target unfolded and misfolded proteins for
degradation. Together, the proposed studies will establish ATF6α as a key profibrotic transcription
factor in HSCs, provide insight into fibrogenic transcription regulated by ATF6α during fibrogenesis,
and identify a critical pro-fibrogenic role for ER-phagy. These studies will help lay the groundwork for my
initial R01 application, facilitating my transition from K01 recipient to independent investigator.
肝硬化是一种全球性的健康危机,是由于慢性肝损伤而引起的。肝损伤激活肝脏
星状细胞(HSC)分化为纤维化肌成纤维细胞。纤维化HSC产生并分泌
大量的基质蛋白存款到细胞外间隙中,导致纤维化,如果不加抑制,
肝硬化虽然纤维化在去除有害刺激后是可逆的,但没有治疗有效地促进纤维化
回归分析由纤维化HSC产生的基质蛋白导致内质网中过量的蛋白质,
内质网(ER),强调ER。内质网应激启动未折叠蛋白反应(UPR),一种信号转导途径。
级联反应允许HSC适应增加的蛋白质负载并促进有效的蛋白质折叠和分泌。
如果ER应激未得到解决,UPR信号从适应性切换到促凋亡。我们建议,
促进HSC适应ER应激的机制将促进HSC凋亡并限制
纤维化,导致体内纤维化消退。初步数据显示,
转录因子6α(ATF 6 α)是UPR的一种转录因子和效应子,对HSC的活化和存活至关重要。
体外和体内纤维化;然而,这种作用的机制尚不清楚。进行RNAseq
在注射CCl 4 4 4周后从小鼠分离的ATF 6 αΔ/Δ HSC上显示基因调控异常,
参与骨化、蛋白质降解、凋亡信号传导、染色质重塑和细胞反应
与从WT小鼠分离的HSC相比,我们假设ATF 6 α激活
促进纤维化HSC适应ER应激的促纤维化转录程序和HSC
生存目的1:研究ATF 6 α调控基因在骨化过程中的作用。
RNAseq对从具有CCl 4诱导的纤维化的小鼠分离的HSC的作用。我们还将使用RNAseq/ATACseq
了解ATF 6 α缺失对HSC的短期转录影响。这些分析将揭示
转录和染色质景观中驱动纤维化的ATF 6 α依赖性变化。目标2将
研究ATF 6 α如何通过ER-吞噬促进HSC存活:ER的选择性自噬降解。ER-
吞噬对于分泌细胞的存活至关重要,但其在HSC和纤维形成中的作用尚不清楚。我们证明,ER-
活化的HSC中吞噬通量增加。此外,ER-吞噬受体在炎症性肝脏中上调,
并且这种上调是ATF 6 α依赖性的。目的2研究ER-吞噬是如何维持ER的
功能并促进HSC存活以驱动纤维化,ATF 6 α如何促进活化的HSC中的ER-吞噬通量,
HSC,以及关键ER吞噬受体靶向未折叠和错误折叠蛋白质的机制
降解总之,拟议的研究将确定ATF 6 α作为关键的促纤维化转录
HSC中的因子,提供了对纤维形成过程中ATF 6 α调控的纤维形成转录的深入了解,
并确定ER吞噬的关键促纤维化作用。这些研究将有助于奠定基础,
最初的R 01申请,帮助我从K 01接收者过渡到独立调查员。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jessica L Maiers其他文献
Jessica L Maiers的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jessica L Maiers', 18)}}的其他基金
Elucidating the Role and Regulation of Proteostasis in Hepatic Fibrogenesis
阐明蛋白质稳态在肝纤维形成中的作用和调节
- 批准号:
10718882 - 财政年份:2023
- 资助金额:
$ 11.89万 - 项目类别:
Elucidating the role of ATF6α as a critical pro-fibrogenic transcription factor in Hepatic Stellate Cells
阐明 ATF6α 作为肝星状细胞中关键的促纤维化转录因子的作用
- 批准号:
10653257 - 财政年份:2022
- 资助金额:
$ 11.89万 - 项目类别:
Identifying targetable mechanisms of TMEM38B/TRIC-B in liver fibrosis
鉴定 TMEM38B/TRIC-B 在肝纤维化中的靶向机制
- 批准号:
10216441 - 财政年份:2021
- 资助金额:
$ 11.89万 - 项目类别:
REGULATION OF HEPATIC FIBROGENEISS BY TANGO1
TANGO1 对肝纤维形成的调节
- 批准号:
10319558 - 财政年份:2018
- 资助金额:
$ 11.89万 - 项目类别:
Regulation of Hepatic Fibrogeneiss by TANGO1
TANGO1 对肝纤维形成的调节
- 批准号:
9447570 - 财政年份:2018
- 资助金额:
$ 11.89万 - 项目类别:
REGULATION OF HEPATIC FIBROGENEISS BY TANGO1
TANGO1 对肝纤维形成的调节
- 批准号:
10369343 - 财政年份:2018
- 资助金额:
$ 11.89万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 11.89万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 11.89万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 11.89万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 11.89万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 11.89万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 11.89万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 11.89万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 11.89万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 11.89万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 11.89万 - 项目类别:
Research Grant














{{item.name}}会员




